Generated by All in One SEO v4.9.3, this is an llms.txt file, used by LLMs to index the site.

# Commercial Eyes

Australia’s leading pharmaceutical and medical device commercialisation company.

## Sitemaps

- [XML Sitemap](https://commercialeyes.com.au/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Insights](https://commercialeyes.com.au/insights/)
- [Strengthening Vendor Assurance: Expert GMP Support for Assessing Overseas Manufacturing Sites ](https://commercialeyes.com.au/strengthening-vendor-assurance-expert-gmp-support-for-assessing-overseas-manufacturing-sites/) - Commercial Eyes offers expert overseas GMP audit support, helping organisations meet vendor assurance requirements and manage risks across international manufacturing sites.
- [When Fuel Runs Low: The Hidden Impact on Medicines and Medical Information Service](https://commercialeyes.com.au/when-fuel-runs-low-the-hidden-impact-on-medicines-and-medical-information-service/) - The global fuel crisis is often discussed in terms of rising petrol prices and economic pressure, but its impact extends far beyond the pump. One of the less visible yet critical consequences is the strain it places on healthcare systems, particularly the supply and availability of medicines. Modern pharmaceutical supply chains depend heavily on fuel to transport raw materials and finished products across the world, meaning even small disruptions can quickly translate into shortages and delays.
- [Introducing Release for Supply (RFS) Services: Supporting Compliance with TGA Expectations](https://commercialeyes.com.au/introducing-release-for-supply-rfs-services-supporting-compliance-with-tga-expectations/) - Looking to ensure compliant, efficient batch release for the Australian market? Our Release for Supply (RFS) services combine global GMP expertise with in-depth knowledge of TGA regulatory requirements.
- [Australia – the Launchpad for Global Clinical Development Success](https://commercialeyes.com.au/australia-the-launchpad-for-global-clinical-development-success/) - Contributing authors to this blog post are Tanya Van der Wall and Nicole (Niki) Gallo. As we prepare, yet again, for Biotech Showcase 2026, held alongside the industry-leading JP Morgan Healthcare Conference, we revisited a conversation that resonated last year around bridging continents for clinical development. Tanya Van der Wall, Regional Managing Director JAPAC at Commercial
- [Pharmacovigilance in Clinical Trials: Where Safety Meets Smart R&D](https://commercialeyes.com.au/pharmacovigilance-in-clinical-trials-where-safety-meets-smart-rd/) - In clinical research, safety builds credibility. Pharmacovigilance (PV) keeps trials safe, compliant, and inspection-ready — ensuring every participant’s well-being and every data point’s reliability. And for sponsors running clinical trials in Australia, partnering with an experienced PV service provider delivers more than compliance confidence — it can also unlock valuable R&D tax savings.
- [Are You Really Meeting Your Quality Management Obligations? ](https://commercialeyes.com.au/are-you-really-meeting-your-quality-management-obligations/) - As a sponsor, supplier or distributor of medicines or medical devices, you must understand your obligations to establish and maintain a fit for purpose Quality Management System (QMS).
- [Did you know Commercial Eyes offers Sponsorship Services in New Zealand as Maxx Pharma NZ Limited?](https://commercialeyes.com.au/did-you-know-commercial-eyes-offers-sponsorship-services-in-new-zealand-as-maxx-pharma-nz-limited/) - Maxx Pharma NZ Limited (Maxx) is a dedicated company offering sponsorship/Marketing Authorisation Holder (MAH) services to organisations looking to register and supply medicines, over-the-counter products and medical devices in New Zealand. Since its launch, Maxx has sponsored over 20 products for multiple clients, including biologicals and general sale medicines.
- [Welcome to Our New Senior Manager, Business Development ](https://commercialeyes.com.au/welcome-to-our-new-senior-manager-business-development/) - We are very pleased to announce Glenn Sprowell has joined Commercial Eyes in the role of Senior Manager, Business Development. Glenn is a seasoned and naturally curious healthcare executive, bringing over 20 years of experience across the pharmaceutical, MedTech, clinical research, healthcare software, and analytics sectors. He has built a successful career driving strategic partnerships
- [Australia’s TGA CPPs Open Doors to Global Pharmaceutical Markets](https://commercialeyes.com.au/australias-tga-cpps-open-doors-to-global-pharmaceutical-markets/) - TGA Certificates of Pharmaceutical Products (CPPs) are a trusted tool for supporting international medicine registrations, offering regulatory credibility and flexibility across a wide range of global markets.
- [ Turning Medical Information into Actionable and Accessible Insights ](https://commercialeyes.com.au/turning-medical-information-into-actionable-and-accessible-insights/) - Why the answers we need are already in our inboxes, phone calls, and reports, if we know how to look.
- [Medical Information in the Post-Pandemic Era: Embracing Change for the Future](https://commercialeyes.com.au/medical-information-in-the-post-pandemic-era-embracing-change-for-the-future/) - The COVID-19 pandemic catapulted Medical Information (MI) into a new era, fast-tracking digital innovation and redefining how we engage and support healthcare professionals in a rapidly evolving landscape.
- [Australia as a Strategic Gateway for Pharmacovigilance Leadership in APAC: Reflections from the ARCS Conference 2025](https://commercialeyes.com.au/australia-as-a-strategic-gateway-for-pharmacovigilance-leadership-in-apac-reflections-from-the-arcs-conference-2025/) - Explore how Australia’s people, partnerships, and regulatory strength position it as a leader in pharmacovigilance across the Asia-Pacific region.
- [Cyclone Alfred: A Wake-Up Call to Strengthen Temperature Excursion Protocols and Elevate Medical Information Services](https://commercialeyes.com.au/cyclone-alfred-a-wake-up-call-to-strengthen-temperature-excursion-protocols-and-elevate-medical-information-services/) - A strategic step forward for Australia’s digital and connected health sector. At Commercial Eyes, we believe in the power of collaboration. Today, we are proud to announce a strategic partnership with ANDHealth, becoming a core partner of Australia’s leading organisation dedicated to the commercialisation of evidence-based digital health technologies. As Australia’s digital health sector accelerates, this partnership reflects our shared ambition: to build a more connected, capable and competitive innovation ecosystem. One where companies can scale safely, strategically, and with confidence.
- [Commercial Eyes is backing Australia’s digital health vision through its partnership with ANDHealth ](https://commercialeyes.com.au/commercial-eyes-is-backing-australias-digital-health-vision-through-its-partnership-with-andhealth/) - A strategic step forward for Australia’s digital and connected health sector. At Commercial Eyes, we believe in the power of collaboration. Today, we are proud to announce a strategic partnership with ANDHealth, becoming a core partner of Australia’s leading organisation dedicated to the commercialisation of evidence-based digital health technologies. As Australia’s digital health sector accelerates, this partnership reflects our shared ambition: to build a more connected, capable and competitive innovation ecosystem. One where companies can scale safely, strategically, and with confidence.
- [Navigating Turbulent Waters: Overcoming Challenges with TGA GMP Clearance Timelines](https://commercialeyes.com.au/navigating-turbulent-waters-overcoming-challenges-with-tga-gmp-clearance-timelines/) - TGA GMP clearance delays are challenging sponsors in Australia. Discover key issues affecting product registrations and supply and explore strategies to navigate these delays.
- [PV Summit 2025 Recap: Are You Inspection-Ready?](https://commercialeyes.com.au/pv-summit-2025-recap-are-you-inspection-ready/) - The ARCS PV Summit 2025 reinforced the critical importance of inspection readiness and sponsor accountability across all product types with the TGA signaling a strategic focus on listed medicines.
- [Health innovation trends for 2025: The era of personalisation, precision, and patient empowerment](https://commercialeyes.com.au/health-innovation-trends-for-2025-the-era-of-personalisation-precision-and-patient-empowerment/) - As health innovation continues to accelerate, 2025 will be another transformative year, driven by several major trends that combine and overlap technology, personalisation, and sustainability. Based on everything we have learned in 2024 from being involved in 100+ projects, attending numerous industry events and analysing a variety of expert opinions, here’s an exploration of the trends poised to redefine healthcare across pharmaceuticals, medical devices, biotechnology, and patient care in 2025 and beyond.
- [Celebrating Our EcoVadis Silver Medal](https://commercialeyes.com.au/celebrating-our-ecovadis-silver-medal/) - Our ongoing commitment to sustainability and ethical practices has led us to achieve the EcoVadis Silver rating after only our second year! This milestone reflects our dedication to continuous improvement and responsible business practices.
- [Season’s Greetings from Commercial Eyes!](https://commercialeyes.com.au/seasons-greetings-from-commercial-eyes/) - We wish you and your loved ones a holiday filled with peace, joy, and cherished moments – and a New Year that brings health, happiness, and prosperity
- [Understanding Risk Management Programs: Ensuring Patient Safety, Regulatory Compliance, and Optimized Therapy](https://commercialeyes.com.au/understanding-risk-management-programs-ensuring-patient-safety-regulatory-compliance-and-optimized-therapy/) - Part 5 of 6: A poorly implemented Risk Management Program (RMP) can erode trust, increase risks, and jeopardise outcomes. Learn how thoughtful design and technology can enhance patient safety, regulatory compliance, and confidence in healthcare.
- [Understanding the unique value proposition and buyer segmentation to develop investor ready research for a global hardware and SaMD company](https://commercialeyes.com.au/understanding-the-unique-value-proposition-and-buyer-segmentation-to-develop-investor-ready-research-for-a-global-hardware-and-samd-company/) - Commercial Eyes’ client, Vitrafy has successfully completed their initial public offering (IPO) on the Australian Securities Exchange (ASX). We unpack the work Commercial Eyes delivered to inform and support the development of their company prospectus
- [At Commercial Eyes, we’re united in the fight against breast cancer—a cause close to our hearts](https://commercialeyes.com.au/at-commercial-eyes-were-united-in-the-fight-against-breast-cancer-a-cause-close-to-our-hearts/) - This year, our team came together for a special Breast Cancer Awareness Bake-off to honor survivors, foster community, and raise funds for research and patient care. With nearly 21,000 Australians expected to face a diagnosis in 2024, every effort matters.
- [ProductLife Group Highlights the Key Role of Artificial Intelligence (AI) in Transforming the Life Sciences Industry](https://commercialeyes.com.au/productlife-group-highlights-the-key-role-of-artificial-intelligence-ai-in-transforming-the-life-sciences-industry/) - Explore ProductLife Group's latest insights on the transformative impact of AI in life sciences. From drug discovery to pharmacovigilance, learn how AI is shaping a smarter future for pharma. With a focus on qualitative research, deep industry expertise, and cutting-edge tools like TrialKey, we provide a clear roadmap to evaluate potential assets and determine whether they align with your strategic objectives.
- [Reflections on ISPOR Europe 2024: Implications for Australia from our Head of Access, Research and Intelligence, Jo Atkins](https://commercialeyes.com.au/reflections-on-ispor-europe-2024/) - The ISPOR Europe 2024 conference, held last week in Barcelona, focused on the theme “Generating Evidence Toward Health and Well-Being.” The conference offered a thought-provoking exploration of how health economics and outcomes research (HEOR) can support evidence-based policy and practice globally. With sessions focusing on the EU joint clinical assessments (JCA) real-world data and AI, and patient-centred research, the conference provided insights that have clear relevance for Australia’s healthcare system.
- [Making the Right Call: Commercial Eyes’ Expertise in Assessing In-Licensing Opportunities](https://commercialeyes.com.au/making-the-right-call-commercial-eyes-expertise-in-assessing-in-licensing-opportunities/) - At Commercial Eyes, we empower our clients to make informed, confident decisions about whether to license a product by offering comprehensive, data-driven assessments that balance clinical promise with commercial viability. With a focus on qualitative research, deep industry expertise, and cutting-edge tools like TrialKey, we provide a clear roadmap to evaluate potential assets and determine whether they align with your strategic objectives.
- [Delivering Critical Therapies to Patients in Need through Managed Access Programs?  Expert execution makes all the difference.](https://commercialeyes.com.au/delivering-critical-therapies-to-patients-in-need-through-managed-access-programs-expert-execution-makes-all-the-difference/) - Outsourcing Managed Access Programs (MAPs) to specialised partners like Commercial Eyes offers pharmaceutical companies the significant advantage of freeing up internal staff time while ensuring ongoing compliance and efficiency.
- [Empowering Patients with Comprehensive Support: How Commercial Eyes' Patient Support Programs Make a Difference](https://commercialeyes.com.au/empowering-patients-with-comprehensive-support-how-commercial-eyes-patient-support-programs-make-a-difference/) - In part three of our six-part series, we focus on how the right design of Patient Support Programs (PSPs) empowers patients and improves outcomes in their treatment journey. At Commercial Eyes, our Patient Support Programs are designed to provide personalised, compassionate care that goes beyond medical treatment. By focusing on sustainability and collaboration with our clients, HCPs, patients and carers, we ensure that our programs remain effective and enduring, helping patients confidently navigate their treatment journey and changing needs over time. i.e. From telehealth services to in-home delivery, our end-to-end services are designed to prioritise the patient experience, enhancing both health outcomes and quality of life throughout their treatment journey.
- [Unlocking Patient Access and HCP experience](https://commercialeyes.com.au/unlocking-patient-access-and-hcp-experience/) - In part two of our six-part series, we dive deeper into Access Programs, which, at their heart, play a pivotal role in bringing innovative treatments to patients prior to launch. While these programs can require significant investment in product, when designed correctly, access programs can provide valuable returns, ensuring that healthcare professionals (HCPs) gain hands-on experience with innovative treatments. Importantly, patients needing life-saving or life-changing treatment can access therapies in that often drawn-out period between registration and reimbursement.
- [Enhancing Health Outcomes through Patient Programs](https://commercialeyes.com.au/enhancing-health-outcomes-through-patient-programs/) - In this 6-part series, we explore how Commercial Eyes designs and delivers a range of different patient programs to address the multifaceted challenges that Healthcare Professionals and patients can encounter whilst trying to access essential treatments.
- [TRoVE database: a treasure chest of competitive insights](https://commercialeyes.com.au/trove-database-a-treasure-chest-of-competitive-insights/) - Powered by TRoVE: discover actionable insights from the latest Medicines Australia transparency reports
- [Decoding Digital Footprints – Part One](https://commercialeyes.com.au/decoding-digital-footprints-part-one/) - The Commercial Eyes' Innovation Series features Q&A interviews with industry leaders, exploring healthcare innovation in Australia. In "Decoding Digital Footprints (Part One)," Salem Lassoued of Data Organica discusses how digital behaviour analysis transforms market research by uncovering true motivations and preferences through real-time data. This approach, combined with traditional methods, provides deeper insights into patient and healthcare professional interactions, enhancing communication strategies and product development.
- [Decoding Digital Footprints – Part Two](https://commercialeyes.com.au/decoding-digital-footprints-part-two/) - The Commercial Eyes' Innovation Series features Q&A interviews with industry leaders to explore healthcare innovation in Australia. In "Decoding Digital Footprints (Part Two)," Salem Lassoued of Data Organica reveals how digital behaviour analysis can uncover unexpected insights about healthcare professionals and patients. This analysis highlights the gap between stated preferences and actual behaviours, emphasizing the importance of understanding real-time data to improve market research, patient engagement, and product development. By integrating digital behaviour analysis with traditional methods, companies can better navigate the complexities of healthcare decision-making and stay ahead of market trends.
- [Digital Health Takes the Main Stage (and All the Other Stages)](https://commercialeyes.com.au/digital-health-takes-the-main-stage-and-all-the-other-stages/) - The Digital Health Festival recently held in Melbourne highlighted the pervasive role of digital health within the healthcare system. This event attracted a massive audience, reflecting the sector’s growth and its evolving focus areas, from aged care to AI, all under the umbrella of digital health. Despite various challenges, the prevailing sentiment was one of optimism about the future of digital health, emphasising its role in transforming healthcare delivery and outcomes.
- [Bridging the Gap with Our Enhanced Patient Safety Services Offerings](https://commercialeyes.com.au/bridging-the-gap-with-our-enhanced-patient-safety-services-offerings/) - Commercial Eyes offers tailored consultation, gap analysis, and business partner audit services to ensure clients are inspection-ready and compliant in pharmacovigilance.
- [Unlocking the Power of Transparency: Competitive Intelligence and the Birth of TRoVE (TRansfer of ValuE)](https://commercialeyes.com.au/introducing-the-trove-database/) - At Commercial Eyes, we are dedicated to staying at the forefront of the pharmaceutical and healthcare industry by developing innovative tools and frameworks that provide valuable insights for our clients. Our latest achievement in this pursuit is the creation of TRoVE (TRansfer of ValuE), a transformative database that elevates the utility of Medicines Australia (MA) Transparency Reports.
- [Unlocking the Potential of AI in Healthcare: Key Insights from the BioMelbourne Network Biosymposium](https://commercialeyes.com.au/unlocking-the-potential-of-ai-in-healthcare-key-insights-from-the-biomelbourne-network-biosymposium/) - Can you anticipate your competitors’ plans & strategies? Can you predict their reactions to your competitive initiatives? Does your competitor have the capabilities to implement their strategy? Do you know your competitors' weaknesses?
- [World Health Day 2024 - Prioritising Health and Wellbeing](https://commercialeyes.com.au/world-health-day-2024-prioritising-health-and-wellbeing/) - On World Health Day, the Commercial Eyes team reflects on the importance of accessing healthcare and how available and supportive wellbeing programs can positively impact our lives.
- [International Women’s Day 2024](https://commercialeyes.com.au/international-womens-day-2024/) - Commercial Eyes was founded on the principles of inclusivity and flexibility, with a mission to empower the women in its workforce. On International Women’s Day, we proudly recognise the outstanding accomplishments of women in the life sciences sector and beyond.
- [Leading Healthcare Transformation through Innovative Solutions](https://commercialeyes.com.au/leading-healthcare-transformation-through-innovative-solutions/) - Healthcare transformation requires innovative solutions. Through our Service Blueprinting work, we align people, process, and tech to measure and improve health and commercial outcomes. Read more about how Commercial Eyes is embracing innovation. Innovation is a broad and often nebulous term. For anyone to work in more innovative ways, it is important to have a clear and consistent definition that makes sense to the business and the people in the context in which they operate.​ At Commercial Eyes, we define innovation from internal and external perspectives: From an
- [12 Insights from the Recent Australian Digital Health Blueprint and Action Plan Launch ](https://commercialeyes.com.au/12-insights-digital-health-blueprint/) - In December 2023, the Australian Federal Department of Health and Aged Care released their digital health blueprint and action plan. Commercial Eyes has identified 12 insights that have short- and long-term implications on the sectors in which we work.
- [Integrated Expertise: Commercial Eyes' Regulatory and Access Teams as Your Gateway to the Australasian Market](https://commercialeyes.com.au/integrated-expertise-commercial-eyes-regulatory-and-access-teams-as-your-gateway-to-the-australasian-market/) - Navigating the complexities of market entry into Australia and New Zealand's pharmaceutical, biotechnology, and MedTech sectors can be daunting; success hinges on navigating complex regulatory and market access pathways. It requires a strategic partner who understands not only the intricacies of healthcare systems but also possesses the capability to navigate rigorous regulatory frameworks and market access challenges.
- [Competitive Intelligence in BANI world](https://commercialeyes.com.au/competitive-intelligence-in-bani-world/) - Can you anticipate your competitors’ plans & strategies? Can you predict their reactions to your competitive initiatives? Does your competitor have the capabilities to implement their strategy? Do you know your competitors' weaknesses?
- [Navigating the Australian Medical Device Market in 2024](https://commercialeyes.com.au/navigating-the-australian-medical-device-market-in-2024/) - Australia stands out as an attractive market for medical devices due to its mature, well-funded, and stable healthcare system. However, breaking into this market is not without its intricacies and challenges
- [Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region](https://commercialeyes.com.au/productlife-group-acquires-commercial-eyes-expanding-its-footprint-in-the-apac-region/) - ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company, specialising in regulatory affairs, pharmacovigilance, medical information, quality assurance, market access, market research, and patient programs.
- [Elevating Patient Voices for Safer Healthcare: Commercial Eyes' Commitment on World Patient Safety Day 2023](https://commercialeyes.com.au/elevating-patient-voices-for-safer-healthcare-commercial-eyes-commitment-on-world-patient-safety-day-2023/) - On World Patient Safety Day 2023, we proudly stand with the global healthcare community, and our clients to Elevate the voice of patients.
- [Navigating the Future of Patient Safety: Insights from ISOP Global Congress in Bali](https://commercialeyes.com.au/navigating-the-future-of-patient-safety-insights-from-isop-global-congress-in-bali/) - Earlier this month, Commercial Eyes’ Patient Safety Manager, Duncan Maher participated in a range of workshops and networking events to prepare and design for the future of Patient Safety and Vigilance at the 2023 Annual Meeting in Bali.
- [Having the Right QPPV Is Essential to Meeting Pharmacovigilance Obligations](https://commercialeyes.com.au/having-the-right-qppv-is-essential-to-meeting-pharmacovigilance-obligations/) - Ensuring the right QPPV is crucial for meeting pharmacovigilance obligations in an evolving landscape of therapeutic goods.
- [Eyes on Health Economics: A Deep Dive by Commercial Eyes](https://commercialeyes.com.au/eyes-on-health-economics-a-deep-dive-by-commercial-eyes/) - An Introduction to Economic Evaluation for Pharma Professionals
- [Extension to TGA Transition Periods for Reclassified Devices and Patient-Matched Devices](https://commercialeyes.com.au/extension-to-tga-transition-periods-for-reclassified-devices-and-patient-matched-devices/) - The Therapeutic Goods Administration (TGA) recently announced that they have received Government approval to extend the transition period affecting most reclassified devices, as well as patient-matched devices, extending the deadline from 1 November 2024 to 1 July 2029.
- [Navigating the Complexities: Health Technology Assessment for Rare Diseases](https://commercialeyes.com.au/navigating-the-complexities-health-technology-assessment-for-rare-diseases/) - The Commercial Eyes Access team recently had the opportunity to attend a seminar ‘Should we use a different HTA process for rare disease treatments?’ organised by Melbourne University, led by renowned health economist Professor Michael Drummond. Here we present some of the key take-aways from this talk along with insights on this important topic.
- [Developments in Thought-Leadership](https://commercialeyes.com.au/developments-in-thought-leadership/) - Identifying the right thought leader is critical in Medical Communications, and with the shift to omnichannel marketing, these leaders are finding new mediums to engage and influence scientific conversation.
- [Supporting Our Support Workers](https://commercialeyes.com.au/supporting-our-support-workers/) - Social workers provide vital support in the healthcare cycle, helping with treatment plans and being a critical communicative link between patients and HCPs. This link can be used to help gain insight into the patient perspective and ensure patients receive the best support.
- [Commercial Eyes Appoints New General Manager](https://commercialeyes.com.au/commercial-eyes-appoints-general-manager/) - We are excited to announce Tanya van der Wall as our new General Manager. With her extensive experience and deep understanding of the industry, Tanya will lead our expert team of consultants, ensuring high-quality services and fostering a culture of collaboration and innovation.
- [World Health Day 2023](https://commercialeyes.com.au/world-health-day-2023/) - On World Health Day 2023, the Commercial Eyes team reflects on the importance of accessing healthcare and how available and supportive wellbeing programs can positively impact our lives.
- [Facing Challenges in Medical Information](https://commercialeyes.com.au/our-expertise-in-medical-information/) - We really do pride ourselves on efficiency and quality. We aim to respond and provide quality information in a timely manner, as we understand the urgency of these enquiries and that some decisions do rely on the information we provide, although the decision is ultimately at the discretion of the prescriber
- [Navigating the Complexities of Medicine Registration](https://commercialeyes.com.au/navigating-the-complexities-of-medicine-registration/) - For a sponsor considering entering the prescription medicine space, it is important to evaluate all the regulatory pathways possible.
- [Understanding Patient Perspectives: The First in our Ongoing Patient Survey Series](https://commercialeyes.com.au/understanding-patient-perspectives-the-first-in-our-ongoing-patient-survey-series/) - In recent years there has been a shift in healthcare towards a more 'patient-centric' approach. However despite this shift, there remains a limited understanding of patients’ perspectives. Here we present the results of our pilot survey to enhance understanding of patient perceptions and expectations.
- [Significant TGA Fee Increases for Medical Devices in FY24](https://commercialeyes.com.au/significant-tga-fee-increases-for-medical-devices-in-fy24/) - The Therapeutic Goods Administration (TGA) have released its consultation paper on the proposed fees & charges model for the 2023-24 Financial year.
- [International Women’s Day 2023](https://commercialeyes.com.au/international-womens-day-2023/) - Commercial Eyes was built on the foundation of a flexible business model designed to embrace and empower the incredible women in our workforce.
- [Medicine repurposing - Why start from scratch?](https://commercialeyes.com.au/medicine-repurposing-why-start-from-scratch/) - As more products are being registered on the Australian Register of Therapeutic Goods (ARTG) for therapeutic claims beyond their original purpose, there is an increasing potential for medicine repurposing.
- [Commercial Eyes focuses on Rare Disease Day 2023](https://commercialeyes.com.au/commercial-eyes-focuses-on-rare-disease-day-2023/) - On Rare Disease Day 2023, the Commercial Eyes team stands with the rare disease community and recognise their strength and resilience. We encourage all stakeholders to work together to support research and development of new treatments and to improve access to care and support for patients and their families. Be proud to be rare and to advocate for a better future for all those affected by rare diseases.
- [Extended hours for Medical Information Service](https://commercialeyes.com.au/extended-hours-for-medical-information-service/) - The need for Medical Information services outside the standard 9am to 5pm AEST business day has become increasingly important and is required by sponsors nationally and globally. With having extended Medical Information hours, Commercial Eyes is able to provide the Medical Information service to meet the regulatory requirements, to cover different time zones in Australia and to also provide coverage to our Asia Pacific clients.
- [A high-quality Medical Information service is an investment in patients and the healthcare system, not a commodity.](https://commercialeyes.com.au/medical-information-service-is-not-a-commodity/) - Despite being readily accessible to patients and health care professionals, Medical Information remains an underutilised resource.
- [2023 Kosi Challenge with Rare Cancers Australia](https://commercialeyes.com.au/2023-kosi-challenge-with-rare-cancers-australia/) - Commercial Eyes to join Rare Cancers Australia in our first Kosi Challenge. The work we do every day with clients and stakeholders confirms how devastating cancer is to the Australian community. Rare cancers pose even greater challenges including late or incorrect diagnosis and limited timely access to clinical trials and new treatments. We have heard the stories of these patients first-hand, and we know from our work with Rare Cancers Australia that substantial funds are required to support these patients’ needs.
- [Pricing & policy decisions: Do you have an external or company only view?](https://commercialeyes.com.au/policy-and-pricing-decisions/) - The effectiveness of one intervention compared to another, also known as the treatment effect, is frequently a key consideration when assessing the cost-effectiveness of alternative therapeutic interventions for economic evaluations.
- [Navigating Significant Safety Issues](https://commercialeyes.com.au/navigating-significant-safety-issues/) - In recent years public expectations for rapid identification and the prompt management of emerging safety issues has grown exponentially, with drug safety coming to the forefront of many consumers' minds.
- [Using Overseas Approvals for Medical Devices to Enter the Australian Market](https://commercialeyes.com.au/using-overseas-approvals-for-medical-devices-to-enter-the-australian-market/) - In May 2017, the TGA issued a public consultation to seek feedback on the proposed use of marketing approval by comparable overseas regulators for devices manufactured overseas, to support inclusion in the Australian Register of Therapeutic Goods (ARTG)
- [The importance of treatment effects in economic evaluation](https://commercialeyes.com.au/the-importance-of-treatment-effects-in-economic-evaluation/) - The effectiveness of one intervention compared to another, also known as the treatment effect, is frequently a key consideration when assessing the cost-effectiveness of alternative therapeutic interventions for economic evaluations.
- [Realising our sustainability objectives, accelerated by the pandemic](https://commercialeyes.com.au/realising-our-sustainability-objectives-accelerated-by-the-pandemic/) - At Commercial Eyes we have a long history of focusing on reducing our environmental footprint in the way we deliver our consulting services. For many years, our office was the first Melbourne high rise to receive the 5-star Green Star Office Design from the Green Building Council of Australia, with a 5 star NABERS water
- [Commercial eyes cheers "sleep at the 'g' "](https://commercialeyes.com.au/sleepattheg/) - Commercial Eyes is delighted that the Melbourne City Mission’s Sleep at the ‘G on Thursday 22 May was well supported again this year with more than 1100 people braving the cold to experience something of the hardships of being homeless.
- [From the frontline of the Nepal earthquake](https://commercialeyes.com.au/from-the-frontline-of-the-nepal-earthquake/) - At our July Conference each year, we relish the opportunity to hear from one of the charities we have supported over the previous 12 months. This year, we were grateful to hear from Margaret Bell, Women’s Health Advisor and Medical Unit Manager with Médecins Sans Frontières (MSF) and to present her with a donation for MSF’s vital work.
- [PBAC Pre-Submission Meetings – What to expect and are they of value?](https://commercialeyes.com.au/pbac-pre-submission-meetings-what-to-expect-and-are-they-of-value/) - Stage 1 PBS Process Improvements commenced 1 July 2019 and included the introduction of changes to pre-submission meetings to provide additional guidance and support for complex submissions.
- [Easing the GMP Clearance burden](https://commercialeyes.com.au/easing-the-gmp-clearance-burden/) - Prior to submitting a new medicine for registration or listing, TGA require the sponsor to have already submitted GMP Clearance applications for overseas sites involved in the manufacture of the medicine
- [Navigating challenges throughout the lifecycle maintenance process can be complex.](https://commercialeyes.com.au/navigating-challenges-throughout-the-lifecycle-maintenance-process-can-be-complex-let-us-take-it-off-your-hands/) - A regulatory agency expectation for the sponsor following the registration of a therapeutic good in Australia or New Zealand is keeping the licence up to date. This is undertaken through submitting variations to the TGA or Medsafe to implement changes to the product and providing the TGA or Medsafe with information upon request.
- [Commercial Eyes Proudly Celebrates 20th Birthday!](https://commercialeyes.com.au/commercial-eyes-proudly-celebrates-20th-birthday/) - From humble beginnings and with big aspirations, on this day 20 years ago Commercial Eyes was founded and over the last two decades has grown to be the foremost therapeutics commercialisation business in Australia and New Zealand.
- [The Top 5 – Tips for Healthy Communication](https://commercialeyes.com.au/the-top-5-tips-for-healthy-communication/) - This month’s Top 5 provides a reminder of what makes for good communication in the health arena.
- [Unfinished Business](https://commercialeyes.com.au/unfinished-business/) - Eye Spy gets to know Andrew Carter, Managing Director and founder of Commercial Eyes Pty Ltd. While single-minded about his business, he is a man of broad vision.
- [Leading From the Front – and Every Angle](https://commercialeyes.com.au/leading-from-the-front-and-every-angle/) - You can instill a ‘leadership culture’ across all areas of your business.
- [People Trends – Reverse to Go Forward](https://commercialeyes.com.au/people-trends-reverse-to-go-forward/) - People Trends is also a new regular feature of Eye Spy. This month we focus on reversing the mentoring process and creating a two-way exchange between the younger and the more experienced personnel.
- [Commercial Eyes puts ideas to Canberra for Innovation Inquiry](https://commercialeyes.com.au/biomelbourneinnovationinquiry/) - Commercial Eyes Managing Director, Andrew Carter was one of a number of industry leaders to attend an invitation only lunch on Tuesday July 1 with the BioMelbourne Network, at which Senator The Hon Kim Carr was the special guest.
- [Commercial Eyes proud to support Frontyard](https://commercialeyes.com.au/commercial-eyes-nfp-support-frontyard-melbournecitymission/) - Sherri Bruinhout, Director, Homelessness & Justice Services at Melbourne City Mission, joined us at the Commercial Eyes all staff conference this month to talk about her experience of working with young people who are homeless, at risk of homelessness, disengaged or requiring support.
- [News from Nigeria](https://commercialeyes.com.au/news-from-nigeria/) - We are proud to support the work of Médecins Sans Frontiéres Australia
- [Commercial Eyes is green through and through](https://commercialeyes.com.au/commercial-eyes-is-green-through-and-through/) - At Commercial Eyes, we believe we have a responsibility to care for and protect the environment. We’ve been committed to improving our environmental performance for many years and are delighted that our new premises at 500 Collins Street has been designed with sustainability at the core.
- [160 years worth celebrating](https://commercialeyes.com.au/160-years-worth-celebrating/) - Commercial Eyes Managing Director, was invited to speak at the celebrations for the 160th anniversary of Melbourne City Mission.
- [6 things you need to know to launch a cosmetic in Australia](https://commercialeyes.com.au/launch-a-cosmetic-in-australia/) - This months top tips focus on what it takes to launch a cosmetic in Australia
- [Andrew Carter – 2014 Pat Clear Award recipient](https://commercialeyes.com.au/pat-clear-award-recipient/) - Andrew Carter is recipient of the 2014 recipient of the Pat Clear Award, Australian medicine industry’s most prestigious award
- [PharmaDispatch: Commercial Eyes founder wins Pat Clear Award](https://commercialeyes.com.au/pharmadispatch-pat-clear/) - Commercial Eyes’ Managing Director, Andrew Carter, features in today’s issue of PharmaDispatch
- [Local pharma expertise and know how: why you need it](https://commercialeyes.com.au/local-pharma-expertise/) - Entering a new marketplace – whether for a medicine, a cosmetic, a device or a complementary medicine – is challenging, time consuming, expensive and often just difficult.
- [Top 5 reasons our staff are glad they made the switch to a role supporting research and big pharma](https://commercialeyes.com.au/top-5-switch-to-role-supporting-research-and-big-pharma/) - In talking with our team we’ve identified five top reasons they’re glad to have made the switch from research or big pharma to a consultancy role supporting research and big pharma.
- [The Purple Truck: driving health outcomes in the Western Desert](https://commercialeyes.com.au/the-purple-truck/) - Commercial Eyes’ Managing Director, and our Finance Director, joined with Katie Whitehead of Medicines Australia to attend the book launch of ‘Patrick Tjungurrayi: Beyond Borders’ last week.
- [FDA tick of approval: Commercial Eyes’ Drug Safety Group has been successfully audited by the FDA!](https://commercialeyes.com.au/tick-of-approval-commercial-eyes-drug-safety-group-has-been-successfully-audited-by-the-fda/) - Commercial Eyes’ Drug Safety Group has been successfully audited by the FDA! Posted on July 15, 2015 Commercial Eyes has been successfully audited by the US Food and Drug Administration (FDA) and found to have no written 483 observations. This is an excellent result that confirms Commercial Eyes’ reputation as the foremost pharmacovigilance and medical information
- [Commercial Eyes has a Victorian Poisons and Controlled Substances Licence](https://commercialeyes.com.au/commercial-eyes-has-a-victorian-poisons-and-controlled-substances-licence/) - The licence facilitates our Regulatory Services department’s product complaints investigations work and enables our Medical Services team to reference the physical product when responding to medical enquiries from patients and healthcare professionals.
- [Commercial Eyes helping to break the cycle of poverty](https://commercialeyes.com.au/commercial-eyes-helping-break-cycle-poverty/) - Andrew Carter, our Managing Director, was fortunate to be able to spend some time with Tara Winkler, Founder and Director of the Cambodian Children’s Trust (CCT), on her recent visit to Melbourne.
- [Innovation in Healthcare: Aligning clinical development and commercial strategies](https://commercialeyes.com.au/innovation-healthcare-aligning-clinical-development-commercial-strategies/) - From penicillin to the human genome, innovation can generate great leaps in science...
- [A PV database to meet your needs… and your budget](https://commercialeyes.com.au/pv-database-to-meet-your-needs-and-your-budget/) - Just as medicines and medical devices are held to stringent quality controls, so too is the software used to support the safety and efficacy of those same medicines and medical devices.
- [Medical Information by instant message](https://commercialeyes.com.au/medical-information-by-instant-message/) - 1800 numbers and written responses such as letters and emails are a well-established part of all Medical Information services. However consumers and healthcare professionals are increasingly tech-savvy.
- [5 reasons to call in the experts: Establishing a pharma business in Australia](https://commercialeyes.com.au/5-reasons-to-call-in-the-experts-establishing-a-pharma-business-in-australia/) - Commercial Eyes has assisted a number of companies to establish a pharma business in Australia, so what are 5 reasons to call in the experts
- [Release for supply – What every sponsor should know](https://commercialeyes.com.au/release-for-supply-what-every-sponsor-should-know/) - Every batch of medicine sold or supplied in Australia is required to have undergone a “release for supply” procedure
- [Using an overseas reference product in your bioequivalence studies](https://commercialeyes.com.au/using-an-overseas-reference-product-in-your-bioequivalence-studies/) - In order to consider whether this process is possible, the TGA have a list of exclusion criteria regarding the use this process.
- [Is our product a medicine, a device, a cosmetic, an OTG or a food… and what could it be?](https://commercialeyes.com.au/is-our-product-a-medicine-a-device-a-cosmetic-an-otg-or-a-food-and-what-could-it-be-regulatory-pathway/) - An increasing number of traditionally pharma/device companies are crossing boundaries to offer their patients a product portfolio spanning several product categories.
- [Keys to off-label communications](https://commercialeyes.com.au/keys-to-off-label-communications/) - The TGA and the Medicines Australia Code of Conduct are very clear on the appropriateness and dissemination of off-label information to HCPs.
- [Stressed? Well your products should be!](https://commercialeyes.com.au/stressed-well-your-products-should-be-forced-degradation-studies/) - Stress-testing is an important validation consideration and should be conducted very early in the development or implementation of new test methods rather than leaving it until regulatory authorities raise questions on the results.
- [Are you eCTD ready?](https://commercialeyes.com.au/are-you-ectd-ready/) - While the eCTD format is not currently mandatory in Australia, it is only a matter of time before the TGA joins other global regulators in mandating eCTD.
- [Medicine labels: TGO 91 and TGO 92. What’s the impact?](https://commercialeyes.com.au/medicine-labels-tgo-91-tgo-92-whats-impact/) - The creation of separate orders for prescription and non-prescription medicines was implemented to reflect how the products are used and ensure adequate information is available for the safe use of products.
- [Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market](https://commercialeyes.com.au/ready-get-setgo-planning-appropriate-strategy-product-enter-australian-market/) - The key to a successful plan is finding the right resources to help us make informed decisions that suit our needs.
- [Warning: This medical device literature review may contain traces of LBS](https://commercialeyes.com.au/warning-medical-device-literature-review-may-contain-traces-lbs/) - With the release of new clinical evidence guidelines for medical devices, sponsors and manufacturers will be expecting some further guidance on the structure, content and quality of their clinical evaluation reports
- [Patient support program - the key driver of better health outcomes](https://commercialeyes.com.au/patient-support-program-the-key-driver-better-health-outcomes/) - Pharmaceutical companies play a key role in supporting the quality use of medicines through patient focused programs. These programs are designed to aid compliance and lifestyle choices.
- [TGA Inspections are Coming – Is your Company Ready?](https://commercialeyes.com.au/tga-inspections-coming-company-ready/) - The TGA has recently concluded its pilot program in Pharmacovigilance inspections in Australia...
- [What is food for special medical purposes (FSMP)?](https://commercialeyes.com.au/food-for-special-medical-purposes-fsmp/) - With a greater recognition of the importance of nutritional support in medical therapy and improved technology, the “food for special medical purposes” market is currently surging
- [Transition to eCTD is gaining momentum in Australia](https://commercialeyes.com.au/transition-ectd-gaining-momentum-australia/) - The TGA announced that applications considered under the priority review pathway will be required to be submitted in eCTD format
- [New 'SmPC' Format for the Australian Product Information](https://commercialeyes.com.au/new-smpc-format-australian-product-information/) - The TGA have published a new form for providing the product information (PI) which means more work for regulatory teams but an enhancement of the quality use of medicines for Australian patients.
- [What is Happening with the Provisional Approval Pathway?](https://commercialeyes.com.au/what-is-happening-with-the-provisional-approval-pathway/) - When the independent review of medicines and medical devices regulation was announced the pharmaceutical sector immediately saw the opportunity for an expediated approval pathway for certain prescription medicines.
- [Life Saving Drugs Program: new lease on life, or on life support?](https://commercialeyes.com.au/life-saving-drugs-program-new-lease-life-life-support/) - The Life Saving Drugs Program currently provides subsidised access to patients with rare and life-threatening conditions to essential and very expensive medicines.
- [The long road to PBS listing for Orkambi](https://commercialeyes.com.au/long-road-pbs-listing-orkambi/) - With its recent stint on Sunrise, Orkambi is a high-profile example of what can occur when both the PBAC and the sponsor are unable to reach agreement on the value of a medicine. Could this evolution of the reimbursement environment extend to current pipeline medicines?
- [Making the most of complementary medicines reforms](https://commercialeyes.com.au/making-complementary-medicines-reforms/) - In March this year the TGA finally started rolling out the long awaited Complementary Medicine Reforms...
- [Are you ready for the mandatory transition to eCTD for prescription medicines?](https://commercialeyes.com.au/ready-mandatory-transition-ectd-prescription-medicines/) - A staged implementation has been proposed for prescription medicines to reflect the current industry uptake of the eCTD format. The transition begins with new chemical entity, new biological entity, biosimilar and new combination medicine applications
- [Patient programs for improved patient outcomes](https://commercialeyes.com.au/patient-programs-improved-patient-outcomes/) - In the digital age of present, patients have never been better equipped with the devices and technologies to take control of their own healthcare needs and outcomes.
- [No CE mark? No problem.](https://commercialeyes.com.au/no-ce-mark-no-problem-ce-mark-may-no-longer-be-an-issue/) - Changes to legislation have increased flexibility for Sponsors looking to market medical devices in Australia...
- [Leukaemia Foundation - Raising Awareness of Blood Cancers](https://commercialeyes.com.au/leukaemia-foundation-raising-awareness-of-blood-cancers/) - Through various parts of our business including market access and insights, regulatory services and medical communications, Commercial Eyes works with a number of organisations involved in improving and extending the lives of people living with leukaemias and other blood cancers.
- [Educating and empowering Indigenous children through Yalari](https://commercialeyes.com.au/educating-and-empowering-indigenous-children-through-yalari/) - Commercial Eyes is honoured to be able to provide ongoing support to educating Indigenous children through Yalari.
- [Commercial Eyes at PharmAus19](https://commercialeyes.com.au/commercial-eyes-at-pharmaus19/) - It is a privilege for the Commercial Eyes team to work closely with so many of the companies represented at PharmAus, to play a key role in making their innovations available to the patients that can benefit from them.
- [ARCS Australia appoints Commercial Eyes Founder and Managing Director to Board.](https://commercialeyes.com.au/arcs-australia-appoints-commercial-eyes-founder-and-managing-director-to-board/) - ARCS Australia has appointed Commercial Eyes Founder and Managing Director, Andrew Carter, to its Board of Directors.
- [Brexit – What’s the impact on medicines and medical devices supplied in Australia?](https://commercialeyes.com.au/brexit-whats-the-impact-on-medicines-and-medical-devices-supplied-in-australia/) - A transition period is now in effect until the end of 2020 with the possibility for extension. Its status quo for Australia during the transition period, with the current regulations for therapeutic goods continuing to apply.
- [(NOT) BUSINESS AS USUAL](https://commercialeyes.com.au/not-business-as-usual/) - At Commercial Eyes, we focus our efforts on supporting clients in the regulated therapeutics industry get their products to the patients who need them, when they need them.
- [Hand sanitiser - What do you need to know to supply in Australia?](https://commercialeyes.com.au/hand-sanitiser-what-do-you-need-to-know-to-supply-in-australia/) - The COVID-19 pandemic has seen the TGA rapidly changing the regulatory landscape for in-demand products that can help reduce the spread of the virus. Given all the changes taking place, it can be difficult to ascertain exactly how product categories have been impacted even day to day.
- [Improved Consumer Medicine Information template](https://commercialeyes.com.au/improved-consumer-medicine-information-template/) - The TGA have now released implementation dates for the updated Consumer Medicine Information (CMI) template
- [Thanks for giving a country kid a go](https://commercialeyes.com.au/thanks-for-giving-a-country-kid-a-go/) - A big thank you, John Kennedy, for giving a kid from the country a go!
- [Coronavirus (COVID-19): Information on medicines and medical devices supply in Australia](https://commercialeyes.com.au/coronavirus-covid-19-information-on-medicines-and-medical-devices-supply-in-australia/) - Access the latest information about the special regulatory requirements for the supply of medicines and devices (including exemptions) in Australia during the pandemic
- [Does social prescribing impact broader health outcomes?](https://commercialeyes.com.au/does-social-prescribing-impact-broader-health-outcomes/) - Whilst the term may be relatively new to mainstream practice in Australia, the idea is not...
- [TGO 91 and TGO 92 - are your labels ready?](https://commercialeyes.com.au/tgo-91-and-tgo-92-are-your-labels-ready/) - Sponsors should check that their medicine labels comply with the relevant TGO...
- [Happy Birthday Commercial Eyes!](https://commercialeyes.com.au/happy-birthday-commercial-eyes/) - In a consulting company, there is no ‘product’ without the people. Without the people, Commercial Eyes Pty Ltd would simply be a ‘legal entity’, without any real function, personality or purpose.
- [A thriving business in dormant times](https://commercialeyes.com.au/a-thriving-business-in-dormant-times/) - We are in the business of assisting clients bring their medicines, medical devices, and diagnostics to the Australian market.
- [Commercial Eyes acquires Open Sesame Consulting](https://commercialeyes.com.au/commercial-eyes-acquires-open-sesame-consulting/) - We are excited to announce the acquisition of Open Sesame Consulting by Commercial Eyes.
- [New TGA framework to redefine personalised medical devices](https://commercialeyes.com.au/new-tga-framework-to-redefine-personalised-medical-devices/) - This post will cover the recent changes brought to regulation of personalised medical devices, under a new TGA framework.
- [International Women’s Day: Celebrating Women at Commercial Eyes](https://commercialeyes.com.au/international-womens-day-celebrating-women-at-commercial-eyes/) - From the beginning, the company has been a workplace that has embraced and rewarded women for the great work that they do.
- [Medical Devices: Reclassification framework of certain devices](https://commercialeyes.com.au/medical-devices-reclassification-framework-of-certain-devices/) - The TGA has commenced the implementation of revised medical device framework...
- [How will the new Strategic Agreements impact your business?](https://commercialeyes.com.au/how-will-the-new-strategic-agreements-impact-your-business/) - Medicines Australia and Generic and Biosimilars Association have secured new 5 year agreements with the Commonwealth for timely access to and reimbursement of medicines and policy settings that recognise the value of innovative and generic medicines to patients and the community.
- [Pandemic disruption and a new MA code update; what for patient programs in this new era?](https://commercialeyes.com.au/pandemic-disruption-and-a-new-ma-code-update-what-for-patient-programs-in-this-new-era/) - COVID-19 has taught us that in times of uncertainty, people seek information and reassurance.
- [Commercial Eyes receives marketing award for product launch campaign](https://commercialeyes.com.au/commercial-eyes-receives-marketing-award-for-product-launch-campaign/) - Congratulations to Associate Director, Dianne Gill and our Medical Communications & Patient Engagement team for receiving a Diamond Award from Consumer Healthcare Products Australia.

## Pages

- [Home](https://commercialeyes.com.au/) - LATEST NEWS Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company Commercial Eyes acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We
- [Quality & Compliance](https://commercialeyes.com.au/services/quality-compliance/) - Our highly experienced Quality and Compliance team brings in-depth expertise in building and maintaining systems that align with GMP and regulatory expectations in Australia and New Zealand.
- [Services](https://commercialeyes.com.au/services/)
- [Regulatory](https://commercialeyes.com.au/services/regulatory-quality-and-compliance/) - OUR IMPACT 90+ Clients across the globe 60+ Major applications on average each year 160+ Regulatory projects in the past 12 months OUR IMPACT
- [Contact us](https://commercialeyes.com.au/contact-us/)
- [Available Positions](https://commercialeyes.com.au/people-and-careers/available-positions/)
- [Disclaimer & Privacy Policy](https://commercialeyes.com.au/disclaimer-privacy-policy/) - This policy applies to Commercial Eyes Pty Ltd (ABN 28 098 247 691) (“Commercial Eyes”, “our”, “we”, “us”) handling, including collection, use, disclosure and storage, of your personal information arising out of, or connected with, our interactions with you, including all personal information collected through ourwebsite (www.commercialeyes.com.au), and in connection with the management of pharmacovigilance cases
- [Grow with us](https://commercialeyes.com.au/people-and-careers/grow-with-us/) - What matters to us Our People The heart of our company.We are fair, inclusive, diverse and prepare future leaders in the regulated human therapeutics sector. Our Community We are more than a business.We're committed to supporting the community in which we work. The projects we support are both sustainable and recurrent including: Yalari, Purple House,
- [About us](https://commercialeyes.com.au/about-us/) - A strong reputation For 22 years we have delivered high quality, customer-focused results in the Australian and New Zealand regulated therapeutics and healthcare industry. Commercial Eyes has grown to become a leading pharmaceutical and medical device commercialisation business. With a team of over 100 people, we have assisted more than 800 clients representing the full
- [Life at Commercial Eyes](https://commercialeyes.com.au/people-and-careers/life-at-commercial-eyes/) - Benefits of working with us Health & Wellbeing Our people have access to the Commercial Eyes EnergEyes Program, which includes an annual wellbeing allowance that can be used to support your health and wellbeing, including but not limited to gym memberships, fitness equipment, activewear, yoga, massage and physio sessions. In addition to this, all employees
- [Our Leaders](https://commercialeyes.com.au/about-us/our-leaders/)
- [Access, Research & Intelligence](https://commercialeyes.com.au/services/access-research-and-intelligence/) - OUR IMPACT 60+ Clients across the globe 12+ Major HTA submissions undertaken on average per year 125+ Access, Research & Intelligence projects undertaken in the past 12 months
- [ESG & Social Impact](https://commercialeyes.com.au/about-us/esg/) - Environmental Sustainability At Commercial Eyes we are committed to protecting the environment, supporting sustainable development and adopting responsible environmental practices in the way we do business. We work closely with our clients to support sustainability targets including meeting global standards for sustainability reporting. Human Dignity & Safety We care about the human impact of the
- [People & Careers](https://commercialeyes.com.au/people-and-careers/)
- [Accreditations](https://commercialeyes.com.au/about-us/accreditations/)
- [Patient Programs](https://commercialeyes.com.au/services/patient-programs/) - OUR IMPACT 20+ Active Programs 10,000+ Active Patients Excellence Feedback from a KOL commented "the best program" he has ever seen - Support Program 2019
- [Patient Safety & Risk Management](https://commercialeyes.com.au/services/patient-safety-and-risk-management/) - OUR IMPACT 9 TGA Inspections with no critical findings 30+ Client audits on average per year 37+ Clients where CEPL is the nominated QPPV-A and/or CPPV-NZ
- [Medical Information](https://commercialeyes.com.au/services/medical-information/) - OUR IMPACT 70+ Clients every year, ranging from big pharma to entrepreneurial start ups 40,000+ Medical enquiries processed each year 3,000+ Product quality complaints handled each year 9,000+ Adverse events reported each year
- [Industry Engagement](https://commercialeyes.com.au/about-us/industry-engagement/) - Memberships Professional Associations
- [People & Careers](https://commercialeyes.com.au/insights/people-careers/)
- [Hot Topics](https://commercialeyes.com.au/insights/hot-topics/)
- [Latest News](https://commercialeyes.com.au/insights/latest-news/)
- [Supporting our Community](https://commercialeyes.com.au/about-us/supporting-our-community/) - Our Community Partners Over the past several years, Commercial Eyes has proudly supported the following not-for-profit organisations. You may like to consider supporting them too.
- [Contact Us](https://commercialeyes.com.au/people-and-careers/available-positions/contact-us/)
- [Newsletter](https://commercialeyes.com.au/newsletter/)
- [Our Purpose](https://commercialeyes.com.au/about-us/our-purpose/)
- [Community Engagement Initiatives](https://commercialeyes.com.au/insights/community-engagement/)
- [Events & Webinars](https://commercialeyes.com.au/insights/events-and-webinars/)

## Team Members

- [Tanya van der Wall](https://commercialeyes.com.au/team-member/tanya-van-der-wall/) - With over 20 years industry experience in boutique law firms and management consultancies, Tanya has developed expertise in strategic analysis and problem solving and has a depth of experience in complex regulatory environments.
- [Grace Kaur](https://commercialeyes.com.au/team-member/grace-kaur/) - With over 12 years’ tenure with Commercial Eyes, Grace is known for her financial and analytical expertise and attention to detail.
- [Lorenza Ricacho](https://commercialeyes.com.au/team-member/lorenza-ricacho/) - Lorenza has been with Commercial Eyes since 2011 and leads our Patient Safety and Risk Management team supporting our clients from the pharmaceutical, medical devices, generics & OTC, cosmetics sectors in Australia, New Zealand and Asia. With over 15 years of experience in the pharmaceutical industry,
- [Maria Dionyssopoulos](https://commercialeyes.com.au/team-member/maria-dionyssopoulos/) - Maria has extensive experience in developing regulatory strategies and providing insightful regulatory advice to a variety of stakeholders.
- [Bree McKenzie](https://commercialeyes.com.au/team-member/bree-mckenzie/) - With over 15 years of experience in brand and marketing communications in health and fast-moving consumer goods. Bree has worked across many therapeutic areas. Bree strongly focuses on patient support via programs, developing support services for organisations, healthcare professionals, and patients with a focus on patient-centric wellbeing and the quality use of medicines.
- [Melissa Sampson-Curry](https://commercialeyes.com.au/team-member/melissa-sampson-curry/) - Melissa joined in the early years of Commercial Eyes, in 2003, and has played a key leadership role in the growth and financial sustainability of the company. Melissa forms part of the strong partnership that has made Commercial Eyes so successful and is also responsible for the management of the Finance, Business Services and Human Resource groups.
- [Wenna Zhang](https://commercialeyes.com.au/team-member/wenna-zhang/) - Wenna leads a team of Medical Information professionals who provide this service to over 30 clients within Asia Pacific. As a team who represents the company to their external customers, Wenna liaises with our clients to ensure that information provided to healthcare professionals and patients is accurate and current.

## Job Vacancies

- [Medical Information Manager](https://commercialeyes.com.au/available-positions/medical-information-manager-3/) - We have a unique opportunity available for an experienced Medical Information Manager to join our Medical Information team. This position reports to the Head of Medical Information.

## Categories

- [Latest News](https://commercialeyes.com.au/category/latest-news/)
- [Events & Webinars](https://commercialeyes.com.au/category/events-and-webinars/)
- [Hot Topics](https://commercialeyes.com.au/category/hot-topics/)

## Tags

- [Regulatory, Quality & Compliance](https://commercialeyes.com.au/tag/regulatory-quality-and-compliance/)
- [Access, Research & Intelligence](https://commercialeyes.com.au/tag/access-research-and-intelligence/)
- [Patient Safety & Risk Management](https://commercialeyes.com.au/tag/patient-safety-and-risk-management/)
- [Medical Information](https://commercialeyes.com.au/tag/medical-information/)
- [Medical Communications & Patient Experience](https://commercialeyes.com.au/tag/medical-communications-and-patient-experience/)
- [Patient Programs](https://commercialeyes.com.au/tag/patient-programs/)
- [People & Careers](https://commercialeyes.com.au/tag/people-and-careers/)
- [ESG & Societal Impact](https://commercialeyes.com.au/tag/esg-and-societal-impact/)
- [Supporting Our Community](https://commercialeyes.com.au/tag/supporting-our-community/)
- [Regulatory](https://commercialeyes.com.au/tag/regulatory/)
- [Quality & Compliance](https://commercialeyes.com.au/tag/quality-compliance/)
- [Access](https://commercialeyes.com.au/tag/access/)
- [Research & Intelligence](https://commercialeyes.com.au/tag/research-intelligence/)
- [Access Research & Intelligence](https://commercialeyes.com.au/tag/access-research-intelligence/)
- [Maria Dionyssopoulos](https://commercialeyes.com.au/tag/maria-dionyssopoulos/)
- [Life at CEPL](https://commercialeyes.com.au/tag/life-at-cepl/)
- [Melissa Sampson-Curry](https://commercialeyes.com.au/tag/melissa-sampson-curry/)
- [Tanya van der Wall](https://commercialeyes.com.au/tag/tanya-van-der-wall/)
- [Jo Atkins](https://commercialeyes.com.au/tag/jo-atkins/)
- [Announcement](https://commercialeyes.com.au/tag/announcement/)
- [AIinHealthcare](https://commercialeyes.com.au/tag/aiinhealthcare/)
- [BioMelbourne](https://commercialeyes.com.au/tag/biomelbourne/)
- [DigitalHealth](https://commercialeyes.com.au/tag/digitalhealth/)
- [HealthcareInnovation](https://commercialeyes.com.au/tag/healthcareinnovation/)
- [PatientCare](https://commercialeyes.com.au/tag/patientcare/)
- [Pharmaceuticals](https://commercialeyes.com.au/tag/pharmaceuticals/)
- [Transparency](https://commercialeyes.com.au/tag/transparency/)
- [Data Analytics](https://commercialeyes.com.au/tag/data-analytics/)
- [Medicines Australia](https://commercialeyes.com.au/tag/medicines-australia/)
- [TRoVE](https://commercialeyes.com.au/tag/trove/)
- [Press Release](https://commercialeyes.com.au/tag/press-release/)
- [Pharmacovigilance](https://commercialeyes.com.au/tag/pharmacovigilance/)
- [ClinicalTrials](https://commercialeyes.com.au/tag/clinicaltrials/)
- [Australia](https://commercialeyes.com.au/tag/australia/)
- [RDTaxIncentive](https://commercialeyes.com.au/tag/rdtaxincentive/)
- [Biotech](https://commercialeyes.com.au/tag/biotech/)
- [LifeSciences](https://commercialeyes.com.au/tag/lifesciences/)
- [DrugSafety](https://commercialeyes.com.au/tag/drugsafety/)
- [PV](https://commercialeyes.com.au/tag/pv/)
- [Compliance](https://commercialeyes.com.au/tag/compliance/)
- [ClinicalResearch](https://commercialeyes.com.au/tag/clinicalresearch/)

## Member Groups

- [Our Leadership](https://commercialeyes.com.au/member_group/leadership-team/)
- [Our Local Company Director](https://commercialeyes.com.au/member_group/our-directors/)